The goal of the Cancer Epidemiology Program is to study environmental, genetic, and molecular risks for cancer and cancer outcomes with an emphasis on disparities. Because we are a public comprehensive cancer center and because North Carolina in many ways mimics the American population, the Program addresses these important questions through multidimensional North Carolina population-based and hospital-based studies. Notable translational cross-program research and high impact publications have been obtained in an inter-disciplinary manner with members of the cancer control and prevention, clinical, genetics, breast, cancer, cell biology and other programs. Program members conduct research with great impact, including population- based studies in breast, colon, prostate, and head and neck cancer, throughout our catchment area (the state of North Carolina) and at UNC Hospital; and the program is focused on cancer health disparities, especially black-white differences. This innovative research model successfully integrates classic risk factor epidemiology, molecular and genetic epidemiology, tumor biology, clinical factors, and prospective follow-up for outcomes. For example, the Program?s Carolina Breast Cancer Study has reshaped our understanding of disparities in breast cancer risk factors, tumor biology, and mortality among African-American women. New and novel North Carolina-based studies in bladder, head and neck, and kidney cancer are planned. Program members collaborate in national and international consortia and with other cancer centers. The Program brings value to the Center through population- and hospital based studies that include systematic collection of exposure, outcome data, and biospecimens, a unique shared resource (Rapid Case Ascertainment), and its expertise in epidemiologic methods development and application. The Program effectively obtains value from the center through UNC Lineberger?s strong support for faculty recruitments, extensive support for important shared resources and developmental funds, which members leverage. The UNC Lineberger strategic plan emphasis on optimizing cancer outcomes in North Carolina led to significant investment across the population sciences including significant faculty recruiting. CE recruited 11 new program members both nationally- recognized senior investigators and promising junior faculty. There are 23 members from 7 different departments in the Schools of Public Health and Medicine and the College of Arts and Sciences. During the last funding period, program members have published 629 cancer- related articles (38% collaborative). In 2014, our program members held 53 grants and $13M (total cost) in annual extramural funding, including 25 grants and $6.6M (total costs) from the NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-44
Application #
9834880
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Anderson, Chelsea; Smitherman, Andrew B; Nichols, Hazel B (2018) Conditional relative survival among long-term survivors of adolescent and young adult cancers. Cancer 124:3037-3043
Liu, Meng-Xi; Jin, Lei; Sun, Si-Jia et al. (2018) Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma. Oncogene 37:1637-1653
Curtis 2nd, Alan D; Jensen, Kara; Van Rompay, Koen K A et al. (2018) A simultaneous oral and intramuscular prime/sublingual boost with a DNA/Modified Vaccinia Ankara viral vector-based vaccine induces simian immunodeficiency virus-specific systemic and mucosal immune responses in juvenile rhesus macaques. J Med Primatol 47:288-297
Williams, Lindsay A; Nichols, Hazel B; Hoadley, Katherine A et al. (2018) Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study. Cancer Causes Control 29:25-32
Amunugama, Ravindra; Willcox, Smaranda; Wu, R Alex et al. (2018) Replication Fork Reversal during DNA Interstrand Crosslink Repair Requires CMG Unloading. Cell Rep 23:3419-3428
Little, Michael S; Pellock, Samuel J; Walton, William G et al. (2018) Structural basis for the regulation of ?-glucuronidase expression by human gut Enterobacteriaceae. Proc Natl Acad Sci U S A 115:E152-E161
Knott, Simon R V; Wagenblast, Elvin; Khan, Showkhin et al. (2018) Erratum: Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 556:135
Dellon, Evan S; Selitsky, Sara R; Genta, Robert M et al. (2018) Gene expression-phenotype associations in adults with eosinophilic esophagitis. Dig Liver Dis 50:804-811
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155
Chai, Zheng; Zhang, Xintao; Rigsbee, Kelly Michelle et al. (2018) Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administration. J Control Release 286:415-424

Showing the most recent 10 out of 1525 publications